Sep 26, 2023, 01:00 by User Not Found

Clinical Research News | Over 900 genes have been implicated in the resistance of tumors to platinum-based chemotherapy that map to many different cellular pathways, thwarting efforts to identify a biomarker to predict refractoriness.

Sep 25, 2023, 08:56 by

Sep 25, 2023, 08:56 by

Sep 25, 2023, 08:56 by

Sep 25, 2023, 08:56 by

Sep 25, 2023, 08:56 by

Sep 25, 2023, 08:56 by

Sep 25, 2023, 08:56 by

Sep 22, 2023, 08:33 by

Sep 22, 2023, 08:33 by

Sep 22, 2023, 08:33 by

Mirikizumab is the first IL-23p19 targeted biologic recommended by NICE for use within NHS England and Wales for treating moderately to severely active ulcerative colitis in adults.1,2. In two randomised, double-blind, placebo-controlled phase 3 trials, LUCENT-1 and LUCENT-2, mirikizumab achieved primary and key secondary endpoints, including sustained clinical remission. Decreases in bowel urgency severity were observed as early as week 2 in patients treated with mirikizumab versus placebo in LUCENT-1.2 Mirikizumab has been recommended through the NICE cost-comparison process meaning NHS England and commissioning groups have agreed to provide funding to implement this guidance within 30 days from publication of the technology appraisal guidance (TAG) rather than the standard 90 days, providing faster access to a new treatment option for eligible adults living with moderately to severely active ulcerative colitis1

Sep 22, 2023, 08:33 by

Sep 22, 2023, 08:33 by

Sep 22, 2023, 01:00 by User Not Found

Clinical Research News | The clinical trial landscape has a long-acknowledged problem – a lack of participant diversity. Most clinical trial participants are from higher-income households, white and male.

Sep 20, 2023, 08:39 by

Nostics, a medical diagnostics startup, is thrilled to announce the appointment of veteran medtech entrepreneur, Jeroen Nieuwenhuis, as its new Chief Executive Officer. As the company prepares to introduce its revolutionary diagnostics technology to the point-of-care market, Jeroen's inclusion marks an important milestone in Nostics’ journey.

Sep 20, 2023, 08:39 by

Mural Health Raises $8M Led by Bessemer Venture Partners to Accelerate Growth Funding enables Mural Health to expand its Mural Link platform to modernize the clinical trial participant experience

Sep 20, 2023, 08:39 by

Sep 20, 2023, 08:39 by

This webinar will present practical strategies to achieve definitive results when researching unstable, sticky, or insoluble compounds.

Sep 20, 2023, 08:39 by

Biofourmis Accelerates and Simplifies Drug Development with Expanded Digital Clinical Trials Solution

Sep 20, 2023, 08:39 by

Health and research tech company uMed is partnering with the Michael J. Fox foundation to run a smell test study to investigate the link between loss of smell and Parkinson’s disease. uMed’s technology and consumer-based marketing techniques will help the Michael J. Fox Foundation overcome traditional barriers to engaging clinical trial volunteers and reach a large, diverse patient cohort to accelerate the pace of research and access to potential breakthroughs.